Review



notch inhibitor dapt  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Tocris notch inhibitor dapt
    (a) αSMA mRNA levels in HCAEC treated with TGFβ1 (10 ng/ml) or exposed to hypoxic conditions (5% O 2 ), in the absence or presence of moderate dose EtOH (25 mM, green bars) or high dose EtOH (100 mM, red bars) +/- the <t>γ-secretase</t> <t>inhibitor</t> <t>DAPT</t> (20 μM). (b) αSMA and fibronectin (FN) mRNA levels in HCAEC treated with TGFβ1 +/- the Notch ligand DLL4 (3 μg/ml) in the absence or presence of DAPT (20 μM). Data are mean±SEM, n=3. *p<0.05 vs control (no treatment), #p<0.05 vs TGFβ1 or hypoxia.
    Notch Inhibitor Dapt, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 509 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/notch inhibitor dapt/product/Tocris
    Average 96 stars, based on 509 article reviews
    notch inhibitor dapt - by Bioz Stars, 2026-06
    96/100 stars

    Images

    1) Product Images from "A Biphasic Effect of Alcohol on Endothelial Plasticity Through Regulation of Endothelial-to-Mesenchymal Transition"

    Article Title: A Biphasic Effect of Alcohol on Endothelial Plasticity Through Regulation of Endothelial-to-Mesenchymal Transition

    Journal: bioRxiv

    doi: 10.64898/2026.04.14.718463

    (a) αSMA mRNA levels in HCAEC treated with TGFβ1 (10 ng/ml) or exposed to hypoxic conditions (5% O 2 ), in the absence or presence of moderate dose EtOH (25 mM, green bars) or high dose EtOH (100 mM, red bars) +/- the γ-secretase inhibitor DAPT (20 μM). (b) αSMA and fibronectin (FN) mRNA levels in HCAEC treated with TGFβ1 +/- the Notch ligand DLL4 (3 μg/ml) in the absence or presence of DAPT (20 μM). Data are mean±SEM, n=3. *p<0.05 vs control (no treatment), #p<0.05 vs TGFβ1 or hypoxia.
    Figure Legend Snippet: (a) αSMA mRNA levels in HCAEC treated with TGFβ1 (10 ng/ml) or exposed to hypoxic conditions (5% O 2 ), in the absence or presence of moderate dose EtOH (25 mM, green bars) or high dose EtOH (100 mM, red bars) +/- the γ-secretase inhibitor DAPT (20 μM). (b) αSMA and fibronectin (FN) mRNA levels in HCAEC treated with TGFβ1 +/- the Notch ligand DLL4 (3 μg/ml) in the absence or presence of DAPT (20 μM). Data are mean±SEM, n=3. *p<0.05 vs control (no treatment), #p<0.05 vs TGFβ1 or hypoxia.

    Techniques Used: Control

    HCAEC were treated with inflammatory cytokines (IL1β + TGFβ1) in the absence or presence of moderate dose ethanol (25 mM EtOH) or high dose ethanol (100 mM EtOH), with or without the gamma secretase inhibitor DAPT (20 μM), before Cdh5 expression was determined by immunocytochemistry. (a) Representative immunofluorescence images from 2 separate experiments, and (b) cumulative quantitative data of Cdh5 fluorescent staining. Data are mean±SEM, n=6. *p<0.05 vs control (no treatment, grp 1), #p<0.05 vs IL1β + TGFβ1 (grp 2).
    Figure Legend Snippet: HCAEC were treated with inflammatory cytokines (IL1β + TGFβ1) in the absence or presence of moderate dose ethanol (25 mM EtOH) or high dose ethanol (100 mM EtOH), with or without the gamma secretase inhibitor DAPT (20 μM), before Cdh5 expression was determined by immunocytochemistry. (a) Representative immunofluorescence images from 2 separate experiments, and (b) cumulative quantitative data of Cdh5 fluorescent staining. Data are mean±SEM, n=6. *p<0.05 vs control (no treatment, grp 1), #p<0.05 vs IL1β + TGFβ1 (grp 2).

    Techniques Used: Expressing, Immunocytochemistry, Immunofluorescence, Staining, Control



    Similar Products

    95
    MedChemExpress notch inhibitors
    Notch Inhibitors, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/notch inhibitors/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    notch inhibitors - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    96
    Tocris notch inhibitor dapt
    (a) αSMA mRNA levels in HCAEC treated with TGFβ1 (10 ng/ml) or exposed to hypoxic conditions (5% O 2 ), in the absence or presence of moderate dose EtOH (25 mM, green bars) or high dose EtOH (100 mM, red bars) +/- the <t>γ-secretase</t> <t>inhibitor</t> <t>DAPT</t> (20 μM). (b) αSMA and fibronectin (FN) mRNA levels in HCAEC treated with TGFβ1 +/- the Notch ligand DLL4 (3 μg/ml) in the absence or presence of DAPT (20 μM). Data are mean±SEM, n=3. *p<0.05 vs control (no treatment), #p<0.05 vs TGFβ1 or hypoxia.
    Notch Inhibitor Dapt, supplied by Tocris, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/notch inhibitor dapt/product/Tocris
    Average 96 stars, based on 1 article reviews
    notch inhibitor dapt - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    96
    Selleck Chemicals notch inhibitor dapt
    <t>Simultaneous</t> <t>TGF-β,</t> ROCK, and Notch pathway inhibition promotes VFE proliferation while maintaining core epithelial phenotype (A) Effect of candidate small-molecule inhibitors on VFE proliferation. Cells (5 × 10 4 ) were incubated with 1 μM A-83-01 (TGF-β inhibitor), 10 μM Y-27632 (ROCK inhibitor), and 5 μM <t>DAPT</t> (Notch inhibitor), as indicated. Counts were performed at day 9; data are plotted as mean ± SEM ( n = 6); p values were obtained using mixed-model ANOVA with planned pairwise comparisons shown. Additional dose-response data for DAPT are presented in . (B) Experimental conditions used for subsequent experiments. Cells in the 3i-VFE condition were incubated with a three-molecule cocktail of 1 μM A-83-01, 10 μM Y-27632, and 5 μM DAPT; cells in the VFE condition were incubated with DMSO vehicle. (C) Bright-field images of live cells at passage 3; all cells exhibited cuboidal morphology over serial passages. Scale bar, 20 μm. (D) Single-passage growth curves and population doubling times. Data are plotted as mean ± SEM ( n = 4); p values were obtained using mixed-model ANOVA. (E) Flow cytometry data showing KRT14 and KRT19 expression. Positive/negative gates (versus unstained controls) are shown in gray. Data are plotted as mean ± SEM ( n = 3); p values were obtained using a paired t test. (F) RT-qPCR data showing TP63 , PROM1 , KIT , CDH1 , and MUC1 transcription; TUBB is reported as an additional reference standard. Data are presented as fold change relative to VFE (mean ± SEM; n = 3); p values were obtained using a paired t test. (G) Transepithelial electrical resistance. Data are plotted as mean ± SEM ( n = 6); the p value was obtained using a paired t test. (H) Flow cytometry data showing CD90 and MUC1 (also known as CD227) expression; VFFs are included as a non-epithelial cell control. High/low gates are shown in black. Data are plotted as mean ± SEM ( n = 3); p values were obtained using paired and unpaired t tests. Note that the 3i-VFE data (light blue) are largely superimposed on the VFE data (dark blue) in the dot plot.
    Notch Inhibitor Dapt, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/notch inhibitor dapt/product/Selleck Chemicals
    Average 96 stars, based on 1 article reviews
    notch inhibitor dapt - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    95
    MedChemExpress notch inhibitors dapt
    ( A ) Percentages of Ki67 + cells among RORγt + ILC3s are shown on the left. Absolute numbers of Ki67 + cells among RORγt + ILC3s are shown on the right. ( B ) Percentages of Ki67 + cells among NKp46 + ILC3s in the intestinal lamina propria. ( C ) Percentages of Ki67 + cells among NKp46 − ILC3s. ( D ) Numbers in flow plots represent percentages of T-bet + NKp46 + cells in the ILC3 gate. ( E ) Percentage of T-bet + cells among NKp46 + ILC3s. ( F ) IFN-γ MFI among NKp46 + ILC3s. ( G ) Percentage of T-bet + cells among DN ILC3s. ( H ) IFN-γ MFI among NKp46 + ILC3s. ( I ) Experimental design for the treatment of 12R-HETE and <t>DAPT.</t> SI LPLs were isolated from the 2-week-old mice. ( J ) Percentages and numbers of NKp46 + ILC3s were analyzed by flow cytometry after Notch signaling inhibitor treatment. ( K ) NKp46 MFI among NKp46 + ILC3. Data are means ± SEM; n = 5 to 6. Each point represents a biological replicate. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001; n.s., not significant.
    Notch Inhibitors Dapt, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/notch inhibitors dapt/product/MedChemExpress
    Average 95 stars, based on 1 article reviews
    notch inhibitors dapt - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    96
    Selleck Chemicals notch gamma secretase inhibitors dapt
    ( A ) Percentages of Ki67 + cells among RORγt + ILC3s are shown on the left. Absolute numbers of Ki67 + cells among RORγt + ILC3s are shown on the right. ( B ) Percentages of Ki67 + cells among NKp46 + ILC3s in the intestinal lamina propria. ( C ) Percentages of Ki67 + cells among NKp46 − ILC3s. ( D ) Numbers in flow plots represent percentages of T-bet + NKp46 + cells in the ILC3 gate. ( E ) Percentage of T-bet + cells among NKp46 + ILC3s. ( F ) IFN-γ MFI among NKp46 + ILC3s. ( G ) Percentage of T-bet + cells among DN ILC3s. ( H ) IFN-γ MFI among NKp46 + ILC3s. ( I ) Experimental design for the treatment of 12R-HETE and <t>DAPT.</t> SI LPLs were isolated from the 2-week-old mice. ( J ) Percentages and numbers of NKp46 + ILC3s were analyzed by flow cytometry after Notch signaling inhibitor treatment. ( K ) NKp46 MFI among NKp46 + ILC3. Data are means ± SEM; n = 5 to 6. Each point represents a biological replicate. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001; n.s., not significant.
    Notch Gamma Secretase Inhibitors Dapt, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/notch gamma secretase inhibitors dapt/product/Selleck Chemicals
    Average 96 stars, based on 1 article reviews
    notch gamma secretase inhibitors dapt - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    Image Search Results


    (a) αSMA mRNA levels in HCAEC treated with TGFβ1 (10 ng/ml) or exposed to hypoxic conditions (5% O 2 ), in the absence or presence of moderate dose EtOH (25 mM, green bars) or high dose EtOH (100 mM, red bars) +/- the γ-secretase inhibitor DAPT (20 μM). (b) αSMA and fibronectin (FN) mRNA levels in HCAEC treated with TGFβ1 +/- the Notch ligand DLL4 (3 μg/ml) in the absence or presence of DAPT (20 μM). Data are mean±SEM, n=3. *p<0.05 vs control (no treatment), #p<0.05 vs TGFβ1 or hypoxia.

    Journal: bioRxiv

    Article Title: A Biphasic Effect of Alcohol on Endothelial Plasticity Through Regulation of Endothelial-to-Mesenchymal Transition

    doi: 10.64898/2026.04.14.718463

    Figure Lengend Snippet: (a) αSMA mRNA levels in HCAEC treated with TGFβ1 (10 ng/ml) or exposed to hypoxic conditions (5% O 2 ), in the absence or presence of moderate dose EtOH (25 mM, green bars) or high dose EtOH (100 mM, red bars) +/- the γ-secretase inhibitor DAPT (20 μM). (b) αSMA and fibronectin (FN) mRNA levels in HCAEC treated with TGFβ1 +/- the Notch ligand DLL4 (3 μg/ml) in the absence or presence of DAPT (20 μM). Data are mean±SEM, n=3. *p<0.05 vs control (no treatment), #p<0.05 vs TGFβ1 or hypoxia.

    Article Snippet: Where indicated, cells were treated with Notch inhibitor DAPT (20 μM, Cat. #2634, Tocris,) or Notch ligand DLL4 (2 μg/ml, Cat. # 1506-D4, R&D Systems).

    Techniques: Control

    HCAEC were treated with inflammatory cytokines (IL1β + TGFβ1) in the absence or presence of moderate dose ethanol (25 mM EtOH) or high dose ethanol (100 mM EtOH), with or without the gamma secretase inhibitor DAPT (20 μM), before Cdh5 expression was determined by immunocytochemistry. (a) Representative immunofluorescence images from 2 separate experiments, and (b) cumulative quantitative data of Cdh5 fluorescent staining. Data are mean±SEM, n=6. *p<0.05 vs control (no treatment, grp 1), #p<0.05 vs IL1β + TGFβ1 (grp 2).

    Journal: bioRxiv

    Article Title: A Biphasic Effect of Alcohol on Endothelial Plasticity Through Regulation of Endothelial-to-Mesenchymal Transition

    doi: 10.64898/2026.04.14.718463

    Figure Lengend Snippet: HCAEC were treated with inflammatory cytokines (IL1β + TGFβ1) in the absence or presence of moderate dose ethanol (25 mM EtOH) or high dose ethanol (100 mM EtOH), with or without the gamma secretase inhibitor DAPT (20 μM), before Cdh5 expression was determined by immunocytochemistry. (a) Representative immunofluorescence images from 2 separate experiments, and (b) cumulative quantitative data of Cdh5 fluorescent staining. Data are mean±SEM, n=6. *p<0.05 vs control (no treatment, grp 1), #p<0.05 vs IL1β + TGFβ1 (grp 2).

    Article Snippet: Where indicated, cells were treated with Notch inhibitor DAPT (20 μM, Cat. #2634, Tocris,) or Notch ligand DLL4 (2 μg/ml, Cat. # 1506-D4, R&D Systems).

    Techniques: Expressing, Immunocytochemistry, Immunofluorescence, Staining, Control

    Simultaneous TGF-β, ROCK, and Notch pathway inhibition promotes VFE proliferation while maintaining core epithelial phenotype (A) Effect of candidate small-molecule inhibitors on VFE proliferation. Cells (5 × 10 4 ) were incubated with 1 μM A-83-01 (TGF-β inhibitor), 10 μM Y-27632 (ROCK inhibitor), and 5 μM DAPT (Notch inhibitor), as indicated. Counts were performed at day 9; data are plotted as mean ± SEM ( n = 6); p values were obtained using mixed-model ANOVA with planned pairwise comparisons shown. Additional dose-response data for DAPT are presented in . (B) Experimental conditions used for subsequent experiments. Cells in the 3i-VFE condition were incubated with a three-molecule cocktail of 1 μM A-83-01, 10 μM Y-27632, and 5 μM DAPT; cells in the VFE condition were incubated with DMSO vehicle. (C) Bright-field images of live cells at passage 3; all cells exhibited cuboidal morphology over serial passages. Scale bar, 20 μm. (D) Single-passage growth curves and population doubling times. Data are plotted as mean ± SEM ( n = 4); p values were obtained using mixed-model ANOVA. (E) Flow cytometry data showing KRT14 and KRT19 expression. Positive/negative gates (versus unstained controls) are shown in gray. Data are plotted as mean ± SEM ( n = 3); p values were obtained using a paired t test. (F) RT-qPCR data showing TP63 , PROM1 , KIT , CDH1 , and MUC1 transcription; TUBB is reported as an additional reference standard. Data are presented as fold change relative to VFE (mean ± SEM; n = 3); p values were obtained using a paired t test. (G) Transepithelial electrical resistance. Data are plotted as mean ± SEM ( n = 6); the p value was obtained using a paired t test. (H) Flow cytometry data showing CD90 and MUC1 (also known as CD227) expression; VFFs are included as a non-epithelial cell control. High/low gates are shown in black. Data are plotted as mean ± SEM ( n = 3); p values were obtained using paired and unpaired t tests. Note that the 3i-VFE data (light blue) are largely superimposed on the VFE data (dark blue) in the dot plot.

    Journal: Cell Reports Methods

    Article Title: Rapid expansion of primary human vocal fold epithelial cells via targeted pathway inhibition and anchorage-independent sphere culture

    doi: 10.1016/j.crmeth.2026.101310

    Figure Lengend Snippet: Simultaneous TGF-β, ROCK, and Notch pathway inhibition promotes VFE proliferation while maintaining core epithelial phenotype (A) Effect of candidate small-molecule inhibitors on VFE proliferation. Cells (5 × 10 4 ) were incubated with 1 μM A-83-01 (TGF-β inhibitor), 10 μM Y-27632 (ROCK inhibitor), and 5 μM DAPT (Notch inhibitor), as indicated. Counts were performed at day 9; data are plotted as mean ± SEM ( n = 6); p values were obtained using mixed-model ANOVA with planned pairwise comparisons shown. Additional dose-response data for DAPT are presented in . (B) Experimental conditions used for subsequent experiments. Cells in the 3i-VFE condition were incubated with a three-molecule cocktail of 1 μM A-83-01, 10 μM Y-27632, and 5 μM DAPT; cells in the VFE condition were incubated with DMSO vehicle. (C) Bright-field images of live cells at passage 3; all cells exhibited cuboidal morphology over serial passages. Scale bar, 20 μm. (D) Single-passage growth curves and population doubling times. Data are plotted as mean ± SEM ( n = 4); p values were obtained using mixed-model ANOVA. (E) Flow cytometry data showing KRT14 and KRT19 expression. Positive/negative gates (versus unstained controls) are shown in gray. Data are plotted as mean ± SEM ( n = 3); p values were obtained using a paired t test. (F) RT-qPCR data showing TP63 , PROM1 , KIT , CDH1 , and MUC1 transcription; TUBB is reported as an additional reference standard. Data are presented as fold change relative to VFE (mean ± SEM; n = 3); p values were obtained using a paired t test. (G) Transepithelial electrical resistance. Data are plotted as mean ± SEM ( n = 6); the p value was obtained using a paired t test. (H) Flow cytometry data showing CD90 and MUC1 (also known as CD227) expression; VFFs are included as a non-epithelial cell control. High/low gates are shown in black. Data are plotted as mean ± SEM ( n = 3); p values were obtained using paired and unpaired t tests. Note that the 3i-VFE data (light blue) are largely superimposed on the VFE data (dark blue) in the dot plot.

    Article Snippet: VFE were seeded in 24-well plates (Corning) at a density of 5 × 10 4 cells per well, cultured in VFE-orientated medium until ∼30% confluent, serum starved for 12 h, then incubated with various combinations of 1 μM TGF-β inhibitor A-83-01, 10 μM ROCK inhibitor Y-27632, and 5 μM Notch inhibitor DAPT (Selleck Chemicals), each prepared from a 1,000× stock solution in DMSO (Thermo Fisher).

    Techniques: Inhibition, Incubation, Flow Cytometry, Expressing, Quantitative RT-PCR, Control

    ( A ) Percentages of Ki67 + cells among RORγt + ILC3s are shown on the left. Absolute numbers of Ki67 + cells among RORγt + ILC3s are shown on the right. ( B ) Percentages of Ki67 + cells among NKp46 + ILC3s in the intestinal lamina propria. ( C ) Percentages of Ki67 + cells among NKp46 − ILC3s. ( D ) Numbers in flow plots represent percentages of T-bet + NKp46 + cells in the ILC3 gate. ( E ) Percentage of T-bet + cells among NKp46 + ILC3s. ( F ) IFN-γ MFI among NKp46 + ILC3s. ( G ) Percentage of T-bet + cells among DN ILC3s. ( H ) IFN-γ MFI among NKp46 + ILC3s. ( I ) Experimental design for the treatment of 12R-HETE and DAPT. SI LPLs were isolated from the 2-week-old mice. ( J ) Percentages and numbers of NKp46 + ILC3s were analyzed by flow cytometry after Notch signaling inhibitor treatment. ( K ) NKp46 MFI among NKp46 + ILC3. Data are means ± SEM; n = 5 to 6. Each point represents a biological replicate. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001; n.s., not significant.

    Journal: Science Advances

    Article Title: 12R-HETE acts as an endogenous ligand for Nur77 in the intestines and regulates NKp46 + ILC3 development

    doi: 10.1126/sciadv.adz8405

    Figure Lengend Snippet: ( A ) Percentages of Ki67 + cells among RORγt + ILC3s are shown on the left. Absolute numbers of Ki67 + cells among RORγt + ILC3s are shown on the right. ( B ) Percentages of Ki67 + cells among NKp46 + ILC3s in the intestinal lamina propria. ( C ) Percentages of Ki67 + cells among NKp46 − ILC3s. ( D ) Numbers in flow plots represent percentages of T-bet + NKp46 + cells in the ILC3 gate. ( E ) Percentage of T-bet + cells among NKp46 + ILC3s. ( F ) IFN-γ MFI among NKp46 + ILC3s. ( G ) Percentage of T-bet + cells among DN ILC3s. ( H ) IFN-γ MFI among NKp46 + ILC3s. ( I ) Experimental design for the treatment of 12R-HETE and DAPT. SI LPLs were isolated from the 2-week-old mice. ( J ) Percentages and numbers of NKp46 + ILC3s were analyzed by flow cytometry after Notch signaling inhibitor treatment. ( K ) NKp46 MFI among NKp46 + ILC3. Data are means ± SEM; n = 5 to 6. Each point represents a biological replicate. * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001; n.s., not significant.

    Article Snippet: In mechanistic experiments, mice were intraperitoneally injected with Notch inhibitors DAPT [MedChemExpress (MCE)] or Impdh1 inhibitors MPA (MCE) after treatment with PBS or 12R-HETE, and animals were euthanized after 10 days.

    Techniques: Isolation, Flow Cytometry